PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, has executed an agreement with MultiPlan, Inc., one of the nation’s largest healthcare preferred provider organization (PPO) networks. The agreement increases the total number of covered lives for RedPath’s patented PathFinderTG® test for pancreatic cancer to more than 74 million people.
Help employers find you! Check out all the jobs and post your resume.
